Live Breaking News & Updates on Formularies Plc

Stay updated with breaking news from Formularies plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Apollon Formularies Announcements | Apollon Formularies: Apollon Formulations Kill Prostate Cancer Cells


 
Apollon Formularies Plc (AQSE: APOL) ( Apollon  
or the  Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange.  ....

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,